Indication

For treatment of advanced (unresectable or metastatic) melanoma in adults and adolescents 12 years of age and over.

Medicine details

Medicine name:
relatlimab / nivolumab (Opdualag)
SMC ID:
SMC2645
Pharmaceutical company
Bristol-Myers Squibb Pharmaceuticals Ltd
BNF chapter
Malignant disease and immunosuppression
Submission type
Full
Publication due date:
TBC
SMC meeting date:
TBC
Patient group submission deadline:
TBC